Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial

Kaspar Broch, Einar Gude, Kristjan Karason, Göran Dellgren, Göran Rådegran, Grunde Gjesdal, Finn Gustafsson, Hans Eiskjær, Jyri Lommi, Markku Pentikäinen, Karl B. Lemström, Arne K. Andreassen, Lars Gullestad

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Cholesterol lowering with EVOLocumab to prevent cardiac allograft Vasculopathy in De-novo heart transplant recipients: Design of the randomized controlled EVOLVD trial'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science